PRP and PMMA Phalloplasty - My Framer Site

PRP and PMMA Phalloplasty

What the Regenerative Evidence Actually Supports

PRP and PMMA Phalloplasty

What the Regenerative Evidence Actually Supports

Dr. Luis Casavantes | Avanti Derma, Tijuana, Mexico

Platelet-rich plasma (PRP) has become one of the most talked-about additions to aesthetic and sexual medicine — and increasingly, patients are asking whether it can be combined with PMMA-based nonsurgical phalloplasty to improve healing or enhance results. It's a fair question, and one worth answering honestly: with a clear look at what PRP actually does, where the evidence is strong, and where it remains exploratory.

What PRP Actually Does

PRP is a biological product derived from the patient's own blood, rich in growth factors and cytokines that play a significant role in tissue regeneration and healing. Mechanistically, its best-documented effect is on collagen. Controlled clinical studies using paired biopsies have shown that PRP increases dermal collagen levels, both through growth factor signaling and through the micro-needling effect of injection itself. By releasing multiple growth factors, PRP stimulates fibroblast proliferation and extracellular matrix synthesis — the same cellular machinery responsible for building the collagen capsule around PMMA microspheres.

This is precisely why the combination is biologically plausible. Preliminary investigations suggest that incorporating PRP into filler protocols may improve biocompatibility, distribution, and tissue integration, potentially reducing adverse effects while enhancing biostimulatory results.

Where the Evidence Is Strong: Penile Regenerative Medicine

PRP's role in andrology is not theoretical — it has a real, growing clinical trial base, primarily in two conditions: Peyronie's disease and erectile dysfunction.

A systematic review identified 17 relevant studies on PRP for these indications. In one study, a mean curvature reduction of roughly 17 degrees was observed, alongside meaningful reductions in pain during intercourse and improvements in erectile function scores. In a separate prospective cohort of 72 patients, three PRP injections two weeks apart reduced median plaque size and penile curvature significantly over four weeks of follow-up.

A randomized, placebo-controlled crossover trial — the gold standard of clinical evidence — found that PRP injections appeared to produce a delayed but real reduction in penile curvature compared to placebo, though the effect size was modest and researchers noted the need for longer-term follow-up. Encouragingly, interim safety data from an 80-patient randomized trial supports that PRP injections can be administered safely in this setting.

This body of work establishes PRP as a legitimate regenerative tool in penile medicine — but it is important to note what it has been studied for. Despite promising signals, current European Association of Urology guidelines still classify PRP as experimental for Peyronie's disease and recommend its use be restricted to clinical trials, given the heterogeneity in preparation protocols, small sample sizes, and short follow-up across existing studies.

Where the Evidence Is Thinner: PRP as a Direct Adjunct to PMMA Augmentation

Here is where honesty matters most. There is currently no published clinical trial evaluating PRP injected specifically alongside PMMA microspheres for penile girth augmentation. The Peyronie's disease and erectile dysfunction data above involve PRP used as a standalone regenerative therapy — not as a co-injected adjunct to a permanent filler.


What we can responsibly say, based on extrapolation from dermal filler research, is this: PRP has been shown to stimulate collagen production and promote tissue regeneration, which in dermal filler applications may extend longevity and improve tissue quality around the implanted material. Since PMMA's permanence depends entirely on the strength and organization of the collagen capsule that forms around its microspheres, a therapy that supports healthy collagen synthesis is, in principle, complementary to the goals of PMMA augmentation.

But "biologically plausible" is not the same as "clinically proven." Until controlled studies specifically test PRP as a peri-procedural adjunct to PMMA phalloplasty — measuring outcomes like nodule formation, capsule quality, and long-term retention — any claims about enhanced results should be presented as a hypothesis, not a guarantee.

How We Approach This at Avanti Derma

Where PRP fits responsibly into our practice today is in its established lane: supporting tissue healing and recovery around the time of a procedure, leveraging the same growth-factor-driven mechanisms documented in the dermal and andrological literature. By stimulating fibroblast activity and extracellular matrix synthesis, PRP may help optimize the healing environment in the days following injection — independent of, and in addition to, the PMMA itself doing what eight years of our own published data show it reliably does.

We do not present PRP as a way to make PMMA more permanent, more effective, or faster-acting, because the data to support that specific claim does not yet exist. We present it as a complementary regenerative therapy with its own track record, used thoughtfully alongside an already well-validated procedure.

The Bigger Principle

The most dangerous trend in regenerative aesthetic medicine is not any single therapy — it's the tendency to bundle exciting new science onto established procedures faster than the evidence can keep up. PRP is genuinely promising. PMMA phalloplasty is genuinely well-studied. The honest position is to let each be evaluated on its own evidence, and to be transparent with patients about which claims are proven and which are still being tested.

That transparency, more than any single technique, is what fifteen years of clinical practice has taught us matters most.

Clinical Takeaways

  • PRP's primary, well-documented mechanism is stimulating collagen synthesis and tissue regeneration via growth factor release.

  • PRP has a growing, though still maturing, evidence base for Peyronie's disease and

    erectile dysfunction, including randomized controlled data.

  • Major urological guidelines still classify PRP as experimental for these indications and recommend restricting use to clinical trials.

  • No published clinical trials currently test PRP co-administered with PMMA for penile

    girth augmentation; the rationale is biologically plausible but clinically unproven.

  • Patients should be told clearly which parts of a regenerative protocol are evidence-based and which are exploratory.

Bibliography

  1. Frontiers in Medicine. "Modulating Rheology and Bioactivity in Dermal Fillers: The

    Emerging Role of Platelet-Rich Plasma (PRP)." Frontiers in Medicine (2025). https://

    www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1728754/full.

  2. Salama, Mostafa, et al. "Platelet-Rich Plasma Therapy in Erectile Dysfunction and

    Peyronie's Disease: A Systematic Review of the Literature." PMC (2024). https://

    pmc.ncbi.nlm.nih.gov/articles/PMC11136842/.

  3. Ramasamy, Ranjith, et al. "A Phase 2 Randomized, Placebo-Controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-Rich Plasma Injections for Peyronie's Disease: Clinical Trial Update." International Journal of Impotence Research (2024). https://doi.org/10.1038/s41443-024-00844-3.

  4. Intralesional Platelet-Rich Plasma for Treating Chronic Peyronie's Disease: A Single-Center Retrospective Cohort Study." PMC (2025). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12844030/.

  5. Achraf, C., A. P. Ammani, and J. El Anzaoui. "Platelet-Rich Plasma in Patients Affected with Peyronie's Disease." Arab Journal of Urology 21 (2023): 69–75. https://doi.org/10.1080/2090598X.2022.2135284.

  6. Gomez Rivas, J., et al. "Platelet-Rich Plasma Intra-Plaque Injections Rapidly Reduce

    Penile Curvature and Improve Sexual Function in Peyronie's Disease Patients: Results from a Prospective Large-Cohort Study." World Journal of Urology (2025). https://link.springer.com/article/10.1007/s00345-025-05691-5.

  7. Suh, D. H., et al. "Histologic Evidence of New Collagen Formation Using Platelet-Rich Plasma in Skin Rejuvenation: A Prospective Controlled Clinical Study." Dermatologic Surgery (2016). https://pubmed.ncbi.nlm.nih.gov/27904271/.

  8. European Association of Urology. "Sexual and Reproductive Health: Penile Curvature." EAU Guidelines, 2022. https://uroweb.org/guideline/sexual-and-reproductive-health/.